{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:21:05Z","timestamp":1783056065954,"version":"3.54.6"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","award":["PSM-2020-085\/1-1"],"award-info":[{"award-number":["PSM-2020-085\/1-1"]}],"id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"National Centre for Research and Development","doi-asserted-by":"publisher","award":["LIDER\/56\/0231\/L-11\/19\/NCBR\/2020"],"award-info":[{"award-number":["LIDER\/56\/0231\/L-11\/19\/NCBR\/2020"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejps.2026.107551","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:33:05Z","timestamp":1778340785000},"page":"107551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oral bioavailability of fenofibrate from melt-extruded phospholipid-containing solid dispersions: A rat study"],"prefix":"10.1016","volume":"222","author":[{"given":"Miko\u0142aj","family":"Czajkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Karbownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Sza\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bauer-Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-6504","authenticated-orcid":false,"given":"Paulina","family":"Skupin-Mrugalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107551_bib0058","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/j.1552-4604.1991.tb03658.x","article-title":"Effects of gravity on gastric emptying, intestinal transit, and drug absorption","volume":"31","author":"Amidon","year":"1991","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107551_bib0014","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/ecco-jcc\/jjaa254","article-title":"Food additive emulsifiers and their impact on gut microbiome, permeability, and inflammation: mechanistic insights in inflammatory bowel disease","volume":"15","author":"Bancil","year":"2021","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.ejps.2026.107551_bib0059","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1113\/jphysiol.1982.sp014383","article-title":"Effects of meal temperature and volume on the emptying of liquid from the human stomach","volume":"331","author":"Bateman","year":"1982","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejps.2026.107551_bib0049","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/mp500545k","article-title":"Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats","volume":"12","author":"Berthelsen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0050","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/mp500545k","article-title":"Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats","volume":"12","author":"Berthelsen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105497","article-title":"(Sub)micron particles forming in aqueous dispersions of amorphous solid dispersions of the poorly soluble drug ABT-199: a combined particle optical counting and field-flow fractionation study","volume":"154","author":"Bohsen","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0002","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/03639045.2021.1908342","article-title":"Ternary solid dispersions: classification and formulation considerations","volume":"47","author":"Borde","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0043","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/03639045.2021.1908342","article-title":"Ternary solid dispersions: classification and formulation considerations","volume":"47","author":"Borde","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0038","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2013.04.002","article-title":"Biopharmaceutical classification of poorly soluble drugs with respect to \u201cenabling formulations","volume":"50","author":"Buckley","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0054","unstructured":"Charakterystyka-14074-2022-07-08-10735_A-2022-07-29, (n.d.)."},{"key":"10.1016\/j.ejps.2026.107551_bib0057","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js960085v","article-title":"Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH","volume":"86","author":"Charman","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0001","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","article-title":"Pharmaceutical applications of solid dispersion systems","volume":"60","author":"Chiou","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123294","article-title":"Hydrogenated phospholipid, a promising excipient in amorphous solid dispersions of fenofibrate for oral delivery: preparation and in-vitro biopharmaceutical characterization","volume":"644","author":"Czajkowski","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106936","article-title":"Melt-extruded formulations of fenofibrate with various grades of hydrogenated phospholipid exhibit promising in-vitro biopharmaceutical behavior","volume":"203","author":"Czajkowski","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107199","article-title":"Dissolution \/permeation of amorphous solid dispersions of fenofibrate & hydrogenated phospholipid - spontaneous formation of colloids: nanofiltration & particle size analysis","volume":"212","author":"Czajkowski","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejps.2015.08.005","article-title":"Phospholipid-based solid drug formulations for oral bioavailability enhancement: a meta-analysis","volume":"80","author":"Fong","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0026","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3549(15)00186-0","article-title":"Solid phospholipid dispersions for oral delivery of poorly soluble drugs: investigation into Celecoxib incorporation and solubility-In vitro permeability enhancement","volume":"105","author":"Fong","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0042","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jps.23979","article-title":"What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?","volume":"103","author":"Frank","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0048","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/03639040500272108","article-title":"Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions","volume":"31","author":"Granero","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-4157(75)90016-7","article-title":"Solubilization of membranes by detergents","volume":"415","author":"Helenius","year":"1975","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Biomembr."},{"key":"10.1016\/j.ejps.2026.107551_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106703","article-title":"Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations","volume":"194","author":"Holzem","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0034","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.xphs.2024.07.017","article-title":"Oral absorption from surfactant-based drug formulations: the impact of molecularly dissolved drug on bioavailability","volume":"113","author":"Holzem","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0039","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the dissolution mechanism of Ritonavir-Copovidone amorphous solid dispersions: importance of congruent release for enhanced performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0027","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejps.2018.11.003","article-title":"A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib","volume":"127","author":"Jacobsen","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0028","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.xphs.2020.08.009","article-title":"Do phospholipids boost or attenuate drug absorption? In vitro and In vivo evaluation of mono- and diacyl phospholipid-based solid dispersions of Celecoxib","volume":"110","author":"Jacobsen","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(98)00345-7","article-title":"Surfactants in membrane solubilisation","volume":"177","author":"Jones","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0037","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejpb.2016.05.017","article-title":"Effect of polymer type and drug dose on the in vitro and in vivo behavior of amorphous solid dispersions","volume":"105","author":"Knopp","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0046","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0005-2760(91)90125-2","article-title":"Effect of fat pre-feeding on bile flow and composition in the rat","volume":"1083","author":"Knox","year":"1991","journal-title":"Biochim. Biophys. Acta (BBA) - Lipids Lipid Metab."},{"key":"10.1016\/j.ejps.2026.107551_bib0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1208\/s12249-019-1366-3","article-title":"Evaluation of hydrogenated soybean phosphatidylcholine matrices prepared by hot melt extrusion for oral controlled delivery of water-soluble drugs","volume":"20","author":"Kolbina","year":"2019","journal-title":"AAPS. Pharm. Sci. Tech."},{"key":"10.1016\/j.ejps.2026.107551_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1208\/s12249-019-1366-3","article-title":"Evaluation of hydrogenated soybean phosphatidylcholine matrices prepared by hot melt extrusion for oral controlled delivery of water-soluble drugs","volume":"20","author":"Kolbina","year":"2019","journal-title":"AAPS. Pharm. Sci. Tech."},{"key":"10.1016\/j.ejps.2026.107551_bib0047","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/03639045.2018.1483395","article-title":"Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note","volume":"44","author":"Lee","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0013","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.autrev.2015.01.009","article-title":"Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease","volume":"14","author":"Lerner","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejps.2026.107551_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-4157(83)90004-7","article-title":"Solubilization of phospholipids by detergents structural and kinetic aspects","volume":"737","author":"Lichtenberg","year":"1983","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Biomembr."},{"key":"10.1016\/j.ejps.2026.107551_bib0052","doi-asserted-by":"crossref","DOI":"10.4021\/cr270w","article-title":"A review of currently available fenofibrate and fenofibric acid formulations","author":"Ling","year":"2013","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.ejps.2026.107551_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103884","article-title":"Untangling \u201cdissolved\u201d drug species from various formulations of a poorly soluble drug: sampling methods, mechanistic insights, and IVIVC","volume":"114","author":"Lynnerup","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107551_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115086","article-title":"Safety of surfactant excipients in oral drug formulations","volume":"202","author":"Maher","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107551_bib0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/oem.41.2.279","article-title":"Is chronic detergent ingestion harmful to the gut?","volume":"41","author":"Mercurius-Taylor","year":"1984","journal-title":"Occup. Env. Med."},{"key":"10.1016\/j.ejps.2026.107551_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105276","article-title":"Amorphous solid dispersions containing residual crystallinity: influence of seed properties and polymer adsorption on dissolution performance","volume":"146","author":"Moseson","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0004","article-title":"Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023","volume":"7","author":"Moseson","year":"2024","journal-title":"Int. J. Pharm.: X"},{"key":"10.1016\/j.ejps.2026.107551_bib0012","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fimmu.2017.00598","article-title":"Leaky gut As a danger signal for autoimmune diseases","volume":"8","author":"Mu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107551_bib0005","series-title":"Pharmaceutical Amorphous Solid Dispersions","year":"2015"},{"key":"10.1016\/j.ejps.2026.107551_bib0044","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/jn\/133.5.1255","article-title":"The addition of soybean phosphatidylcholine to triglyceride increases suppressive effects on food intake and gastric emptying in rats","volume":"133","author":"Nishimukai","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejps.2026.107551_bib0051","unstructured":"F. Otto, Assessment of the applicability of HLB values for natural phospholipid emulsifiers for preparation of stable emulsions, (n.d.)."},{"key":"10.1016\/j.ejps.2026.107551_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1208\/s12248-021-00667-w","article-title":"Exploring the relationship of drug BCS classification, food effect, and gastric pH-dependent drug interactions","volume":"24","author":"Owens","year":"2021","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2026.107551_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105262","article-title":"Polymer\/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug","volume":"146","author":"Peng","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0056","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2016.04.013","article-title":"Prediction of positive food effect: bioavailability enhancement of BCS class II drugs","volume":"506","author":"Raman","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2015.04.001","article-title":"Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine","volume":"74","author":"Shi","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0032","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.09.001","article-title":"Dynamic dissolution-\/permeation-testing of nano- and microparticle formulations of fenofibrate","volume":"96","author":"Sironi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0031","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpb.2020.05.021","article-title":"The influence of liquid intake on the performance of an amorphous solid dispersion in rats","volume":"152","author":"Sironi","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0029","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1021\/acs.molpharmaceut.7b00735","article-title":"Extraordinary long-term-stability in kinetically stabilized amorphous solid dispersions of fenofibrate","volume":"14","author":"Theil","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107551_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2010.02.003","article-title":"Formation of nano\/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media","volume":"40","author":"Tho","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib60","unstructured":"U.S. Food and Drug Administration, 2013. 21CFR184.1400 revised as of April 1, 2013."},{"key":"10.1016\/j.ejps.2026.107551_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.07.008","article-title":"Review \u2013 An update on the use of oral phospholipid excipients","volume":"108","author":"van Hoogevest","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/0008-5472.CAN-16-1359","article-title":"Dietary emulsifier\u2013Induced low-grade inflammation promotes colon carcinogenesis","volume":"77","author":"Viennois","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2026.107551_bib0003","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1021\/acs.cgd.5c00417","article-title":"Impact of surfactants as formulation additives and Media components on the performance of amorphous solid dispersions","volume":"25","author":"Zhang","year":"2025","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107551_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejps.2018.10.020","article-title":"Effect of plasticizers on manufacturing ritonavir\/copovidone solid dispersions via hot-melt extrusion: preformulation, physicochemical characterization, and pharmacokinetics in rats","volume":"127","author":"Zhao","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2019.04.022","article-title":"Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus","volume":"134","author":"Zi","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107551_bib0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/pharmaceutics12090817","article-title":"Nicardipine loaded solid phospholipid extrudates for the prevention of cerebral vasospasms: in vitro characterization","volume":"12","author":"Zlomke","year":"2020","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:02:59Z","timestamp":1783054979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"alternative-id":["S0928098726001259"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107551","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral bioavailability of fenofibrate from melt-extruded phospholipid-containing solid dispersions: A rat study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107551"}}